RecruitingNot ApplicableNCT06396260
Structural and Functional Networks in ALS: An Insight Into Pseudobulbar Affect
Sponsor
Aalborg University Hospital
Enrollment
50 participants
Start Date
May 26, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The investigators aim to elucidate characteristics of structural and functional brain connectivity in patients with amyotrophic lateral sclerosis (ALS) and pseudobulbar affect (PBA) using diffusion kurtosis imaging (DKI) and magnetoencephalography (MEG).
Eligibility
Min Age: 18 YearsMax Age: 90 Years
Inclusion Criteria1
- Diagnosed with ALS in the last 6 months according to Gold Coast Criteria
Exclusion Criteria14
- \- Lack of ability to answer survey through own ability or through a surrogate, for example by hand controlled, eye-controlled computer and/or tablet, or through telephone interview.
- Lack of ability to cooperate.
- Pregnancy
- Drug addiction defined as the non-prescribed use of cannabis, opioids, or other narcotics.
- Alcohol addiction defined as over 21 units weekly.
- Lesional neurological diseases, such as stroke, tumor or multiple sclerosis
- Epilepsy
- Neurodegenerative diseases other than ALS
- Severe psychiatric disease such as major depression disorder, bipolar disease or schizophrenia
- Contraindication for MRI and MEG scan according to hospital guidelines
- Severe liver or kidney disease
- Dysregulated heart disease
- Ongoing treatment with any antidepressants or any antipsychotics at recruitment.
- Diagnosed with frontotemporal dementia.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERDiffusion Kurtosis Imaging (DKI)
Non-invasive MRI sequence which extracts information of diffusion signals from complex brain tissue
OTHERResting State Magnetoencephalography
Non-invasive method of measuring resting state brain activity through magnetoencephalography (MEG)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06396260
Related Trials
HEALEY ALS Platform Trial - Master Protocol
NCT0429768378 locations
Ultra-high-caloric, Fatty Diet in ALS
NCT0628007923 locations
TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
NCT067265771 location
A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
NCT072900625 locations
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
NCT0728739711 locations